BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28751568)

  • 1. mTOR (Mechanistic Target of Rapamycin) Inhibition Decreases Mechanosignaling, Collagen Accumulation, and Stiffening of the Thoracic Aorta in Elastin-Deficient Mice.
    Jiao Y; Li G; Li Q; Ali R; Qin L; Li W; Qyang Y; Greif DM; Geirsson A; Humphrey JD; Tellides G
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1657-1666. PubMed ID: 28751568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient Circumferential Growth Is the Primary Determinant of Aortic Obstruction Attributable to Partial Elastin Deficiency.
    Jiao Y; Li G; Korneva A; Caulk AW; Qin L; Bersi MR; Li Q; Li W; Mecham RP; Humphrey JD; Tellides G
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):930-941. PubMed ID: 28254817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin inhibits smooth muscle cell proliferation and obstructive arteriopathy attributable to elastin deficiency.
    Li W; Li Q; Qin L; Ali R; Qyang Y; Tassabehji M; Pober BR; Sessa WC; Giordano FJ; Tellides G
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1028-35. PubMed ID: 23493289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.
    Zhao Y; Zhao MM; Cai Y; Zheng MF; Sun WL; Zhang SY; Kong W; Gu J; Wang X; Xu MJ
    Kidney Int; 2015 Oct; 88(4):711-21. PubMed ID: 26061549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically Improved Contractility Protects Against Aortic Dissection in Mice With Disrupted Transforming Growth Factor-β Signaling Despite Compromised Extracellular Matrix Properties.
    Ferruzzi J; Murtada SI; Li G; Jiao Y; Uman S; Ting MY; Tellides G; Humphrey JD
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):919-27. PubMed ID: 26988590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus Rescues the Phenotype of Elastin Insufficiency in Patient Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.
    Kinnear C; Agrawal R; Loo C; Pahnke A; Rodrigues DC; Thompson T; Akinrinade O; Ahadian S; Keeley F; Radisic M; Mital S; Ellis J
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1325-1339. PubMed ID: 32212852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion.
    Li G; Qin L; Wang L; Li X; Caulk AW; Zhang J; Chen PY; Xin S
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1110-H1119. PubMed ID: 28213405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin prevents thoracic aortic aneurysm and dissection in mice.
    Zhou B; Li W; Zhao G; Yu B; Ma B; Liu Z; Xie N; Fu Y; Gong Z; Dai R; Zhang X; Kong W
    J Vasc Surg; 2019 Mar; 69(3):921-932.e3. PubMed ID: 30253896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.
    Hu JH; Wei H; Jaffe M; Airhart N; Du L; Angelov SN; Yan J; Allen JK; Kang I; Wight TN; Fox K; Smith A; Enstrom R; Dichek DA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2647-56. PubMed ID: 26494233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical behavior and matrisome gene expression in the aneurysm-prone thoracic aorta of newborn lysyl oxidase knockout mice.
    Staiculescu MC; Kim J; Mecham RP; Wagenseil JE
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H446-H456. PubMed ID: 28550176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of murine thoracic aortic structural and cellular changes with aging to passive and active mechanical properties.
    Wheeler JB; Mukherjee R; Stroud RE; Jones JA; Ikonomidis JS
    J Am Heart Assoc; 2015 Feb; 4(3):e001744. PubMed ID: 25716945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).
    Feldman ME; Shokat KM
    Curr Top Microbiol Immunol; 2010; 347():241-62. PubMed ID: 20549474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm.
    Shen M; Lee J; Basu R; Sakamuri SS; Wang X; Fan D; Kassiri Z
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):888-98. PubMed ID: 25657308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.
    Cao J; Gong L; Guo DC; Mietzsch U; Kuang SQ; Kwartler CS; Safi H; Estrera A; Gambello MJ; Milewicz DM
    Hum Mol Genet; 2010 May; 19(10):1908-20. PubMed ID: 20159776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Matrix Disarray as a Mechanism for Greater Abdominal Versus Thoracic Aortic Stiffness With Aging in Primates.
    Zhang J; Zhao X; Vatner DE; McNulty T; Bishop S; Sun Z; Shen YT; Chen L; Meininger GA; Vatner SF
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):700-6. PubMed ID: 26891739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastin haploinsufficiency induces alternative aging processes in the aorta.
    Pezet M; Jacob MP; Escoubet B; Gheduzzi D; Tillet E; Perret P; Huber P; Quaglino D; Vranckx R; Li DY; Starcher B; Boyle WA; Mecham RP; Faury G
    Rejuvenation Res; 2008 Feb; 11(1):97-112. PubMed ID: 18173368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
    Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
    Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho upregulation by rapamycin protects against vascular disease in CKD.
    Hamano T
    Kidney Int; 2015 Oct; 88(4):660-2. PubMed ID: 26422620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.